Ad is loading...
SLS
Price
$1.21
Change
-$0.01 (-0.82%)
Updated
Nov 22, 03:36 PM (EDT)
118 days until earnings call
SNPX
Price
$2.46
Change
-$0.11 (-4.28%)
Updated
Nov 22, 12:15 PM (EDT)
Ad is loading...

SLS vs SNPX

Header iconSLS vs SNPX Comparison
Open Charts SLS vs SNPXBanner chart's image
SELLAS Life Sciences Group
Price$1.21
Change-$0.01 (-0.82%)
Volume$500
CapitalizationN/A
Synaptogenix
Price$2.46
Change-$0.11 (-4.28%)
Volume$500
CapitalizationN/A
SLS vs SNPX Comparison Chart
Loading...
SLS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SNPX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
SLS vs. SNPX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLS is a StrongSell and SNPX is a Sell.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (SLS: $1.22 vs. SNPX: $2.57)
Brand notoriety: SLS and SNPX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SLS: 120% vs. SNPX: 14%
Market capitalization -- SLS: $85.87M vs. SNPX: $3.48M
SLS [@Biotechnology] is valued at $85.87M. SNPX’s [@Biotechnology] market capitalization is $3.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SLS’s FA Score shows that 0 FA rating(s) are green whileSNPX’s FA Score has 2 green FA rating(s).

  • SLS’s FA Score: 0 green, 5 red.
  • SNPX’s FA Score: 2 green, 3 red.
According to our system of comparison, SNPX is a better buy in the long-term than SLS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SLS’s TA Score shows that 5 TA indicator(s) are bullish while SNPX’s TA Score has 4 bullish TA indicator(s).

  • SLS’s TA Score: 5 bullish, 6 bearish.
  • SNPX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both SLS and SNPX are a bad buy in the short-term.

Price Growth

SLS (@Biotechnology) experienced а -3.94% price change this week, while SNPX (@Biotechnology) price change was -1.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.14%. For the same industry, the average monthly price growth was -4.98%, and the average quarterly price growth was +4.01%.

Reported Earning Dates

SLS is expected to report earnings on Mar 20, 2025.

SNPX is expected to report earnings on May 29, 2024.

Industries' Descriptions

@Biotechnology (+2.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLS($85.9M) has a higher market cap than SNPX($3.48M). SLS YTD gains are higher at: 15.094 vs. SNPX (-62.266). SNPX has higher annual earnings (EBITDA): -6.76M vs. SLS (-32.77M). SNPX has more cash in the bank: 22.1M vs. SLS (21M). SLS (0) and SNPX (0) have equivalent revenues.
SLSSNPXSLS / SNPX
Capitalization85.9M3.48M2,471%
EBITDA-32.77M-6.76M485%
Gain YTD15.094-62.266-24%
P/E RatioN/A2.91-
Revenue00-
Total Cash21M22.1M95%
Total Debt576KN/A-
FUNDAMENTALS RATINGS
SLS: Fundamental Ratings
SLS
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SLSSNPX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
85%
Bullish Trend 16 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
SLS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SNPX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LGHL0.200.01
+3.16%
Lion Group Holding Ltd
GCTS2.230.05
+2.29%
GCT Semiconductor Holding
PSEC4.650.06
+1.31%
Prospect Capital Corp
WEX181.731.41
+0.78%
WEX
TXO18.01N/A
N/A
TXO Partners LP

SLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLS has been loosely correlated with FULC. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SLS jumps, then FULC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLS
1D Price
Change %
SLS100%
-1.61%
FULC - SLS
48%
Loosely correlated
-0.67%
NKTR - SLS
42%
Loosely correlated
+1.00%
SNPX - SLS
34%
Loosely correlated
-3.24%
AXON - SLS
32%
Poorly correlated
+3.52%
MDGL - SLS
30%
Poorly correlated
+3.83%
More

SNPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNPX has been closely correlated with NCNA. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if SNPX jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNPX
1D Price
Change %
SNPX100%
-3.24%
NCNA - SNPX
92%
Closely correlated
-0.78%
RNAC - SNPX
91%
Closely correlated
-1.89%
AGEN - SNPX
91%
Closely correlated
+7.12%
ALLR - SNPX
87%
Closely correlated
+5.88%
NRXP - SNPX
84%
Closely correlated
+1.65%
More